Study questions US FDA's shorter drug approval times
Study questions US FDA's shorter drug approval times
Filed under: drug treatment programs in dc
Washington DC, USA (Reuters) – New drugs that receive expedited review by the Food and Drug Administration are being tested on fewer patients, leaving many safety questions unanswered even after they are approved, a study released on Monday in the …
Read more on Solar News
AMAG's FDA nod for Feraheme in broad iron deficiency may see further delays …
Filed under: drug treatment programs in dc
Concerns about anaphylaxis affect all IV irons, not just Feraheme, so FDA needing additional safety studies are doubtful, said Dr Mahesh Krishnan, vice president, clinical research, DaVita Clinical Research, Washington, DC. The drug already has …
Read more on Financial Times
MedStar Heart Institute and Infraredx, Inc Initiate the Lipid Rich Plaque (LRP …
Filed under: drug treatment programs in dc
We can then utilize treatment modalities, drug or device, or a combination, to help mitigate this risk," said Dr. Waksman. "We are excited to start and conduct this monumental … MedStar Heart Institute, headquartered at MedStar Washington Hospital …
Read more on 4-traders (press release)